Thermo Fisher Expands Menu to Offset COVID-19 Decreases

By Robert Michel | From the Volume XXIX, No. 14 – October 10, 2022 Issue

IT’S NOT JUST CLINICAL LABORATORIES seeking ways to repurpose the analyzers and automation they used to perform SARS-CoV-2 testing. As the pandemic continues to ease, some in vitro diagnostics (IVD) companies want to help their lab customers by expanding the types of diagnostic tests than can …

Read More

---

2021 Rankings of the World’s Top 12 IVD Companies

By Robert Michel | From the Volume XXIX, No. 12 – August 29, 2022 Issue

WHILE THERE WAS SOME JOCKEYING FOR NEW positions, in vitro diagnostics (IVD) manufacturers remain entrenched in their market based on The Dark Report’s 2021 ranking of the Top 12 IVD Companies.  COVID-1…

Read More

---

Public Laboratory Companies Eye More Lab Outreach Acquisitions

By Robert Michel | From the Volume XXIX, No. 12 – August 29, 2022 Issue

PUBLICLY-TRADED CLINICAL LABORATORY COMPANIES released second quarter 2022 financial reports that confirmed a softening demand for COVID-19 tests, even as their base business revenues grew compared to last year.  While continuing to address ongoing needs…

Read More

---

Lab Vendors Adjusting to Changing Sales Practices

By Robert Michel | From the Volume XXIX, No. 8 – June 6, 2022 Issue

…

Read More

---

How Northwell’s Lab Team Demonstrated Value Over 10 Years

By Joseph Burns

CEO SUMMARY: Among hospital administrators, the popular wisdom is that their clinical lab is a cost center. This thinking leads them to consider drastic cost-management strategies that include partnering with commercial labs to manage in-hospital lab testing and the outright sale of lab o…

Read More

---

Pathology Groups Should Plan to Use Digital Pathology

By Pamela Scherer McLeod

WHEN AN ANATOMIC PATHOLOGY GROUP CONSIDERS IMPLEMENTING digital pathology and whole-slide imaging (WSI) for primary diagnosis, it must identify and understand a range of challenges and opportunities. “Every pathology group should start by considering how it will use the related technologies of a…

Read More

---

How Labs Can Add Value for Providers, Insurers, Pharma

By Joseph Burns | From the Volume XXVI No. 15 – November 4, 2019 Issue

CEO SUMMARY: For pathologists and clinical, molecular, and genetic testing labs, appropriate reuses of lab data can provide a new source of revenue. Labs that serve as preferred providers of diagnostic testing data can help health systems, ordering physicians, pharmaceutical companies, an…

Read More

---

Fewer Pathologists Means Tighter Market for Jobs

By Joseph Burns | From the Volume XXVI No. 8 – June 10, 2019 Issue

CEO SUMMARY: Pathologists seeking jobs will find that a more competitive job market is pushing salaries up over $300,000 per year on average. In addition, most new jobs come with a hiring bonus and funds for relocation of as much as $12,000 and for continuing medical education of $3,500. …

Read More

---

Northwell Health Lab Team Leverages Data to Add Value

By Joseph Burns | From the Volume XXVI No. 8 – June 10, 2019 Issue

CEO SUMMARY: Today, insurers get risk-adjusted payments for treating patients who have high-cost health conditions and they make risk-adjusted payments to physicians, hospitals, and other providers. At Northwell Health, the clinical lab saw the opportunity to leverage lab test data with …

Read More

---

LIS-EHR Fees Increasing, Say Hospital Lab Execs

By Joseph Burns | From the Volume XXVI No. 4 – March 18, 2019 Issue

CEO SUMMARY: Hospital and health system lab managers say some vendors of electronic health record systems for independent physicians are aggressively raising the fees they charge labs. Labs serving outreach physicians now pay more in two ways, they say. First, they pay the price the vendo…

Read More

---